Smega Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Belapur, Maharashtra, India, established in 2011.
2011 Belapur, Maharashtra, India Active
Last Updated:
Access Report
About Smega Pharmaceuticals Private Limited

Smega Pharmaceuticals Private Limited, a active private limited company, was established on 14 November 2011 in Belapur, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51909MH2011PTC223917. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.20 M and a paid-up capital of ₹0.14 M.

It upholds a compliant status. Its leadership includes Gautam Kumar Aniruddha Das (Director), Madhav Gaikwad Tulsiram (Director), Nilesh Laxman Gajmal (Director). Past directors included Gautam Kumar Aniruddha Das, Sumedh Gaikwad Madhav. It holds ₹4.00 M open charges and no settled loans. Its latest AGM occurred on 27 September 2019, with the balance sheet filed on 31 March 2019. It is based at Office No.607, 6Th Floor, A-Wing Hermes Antrium Plot No.57, Sec-11,, Belapur, Maharashtra, 400614.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51909MH2011PTC223917

  • Registration Number

    223917

  • Incorporation Date

    14 November 2011

  • Authorized Capital

    ₹0.20 M

  • Paid-Up Capital

    ₹0.14 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.20 M
  • Paid Up Capital ₹ 0.14 M
  • Company Age 14 Year, 4 Months
  • Last Filing with ROC 31 Mar 2019
  • Open Charges ₹ 4.00 M
  • Revenue Growth **** -41.23%
  • Profit Growth **** -21120.74%
  • Ebitda **** -596.39%
  • Net Worth -19.94%
  • Total Assets **** 48.83%
Company report

Smega Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Smega Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Smega Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Gautam Kumar Aniruddha Das Director 14 Nov 2011 Current
Madhav Gaikwad Tulsiram Director 10 Jan 2017 Current
Nilesh Laxman Gajmal Director 27 Dec 2016 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 30 Sep 2021 Past
Pramod Abcsdd Director 10 Jan 2017 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Smega Pharmaceuticals.

Smega Pharmaceuticals Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 41.23% decrease. The company also saw a substantial fall in profitability, with a 21120.74% decrease in profit. The company's net worth observed a substantial decline by a decrease of 19.94%.

Smega Pharmaceuticals revenue growth over time
Smega Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -41.23%
*******
*******
*******
*******
Revenue from Operations
*******
 -38.63%
*******
*******
*******
*******
Total Assets
*******
 48.83%
*******
*******
*******
*******
Profit or Loss
*******
 -21120.74%
*******
*******
*******
*******
Net Worth
*******
 -19.94%
*******
*******
*******
*******
EBITDA
*******
 -596.39%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Smega Pharmaceuticals?

In 2019, Smega Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹4,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • State Bank Of Hyderabad : 0.40 Cr
Latest Charge Details
Date Lender Amount Status
20 Jan 2015 State Bank Of Hyderabad ₹4.00 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Smega Pharmaceuticals?

Unlock and access historical data on people associated with Smega Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Smega Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Smega Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Smega Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Smega Pharmaceuticals Private Limited last Annual general meeting of members was held on 27 Sep 2019 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Smega Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Mumbai. was completed.

  • Director Appointment

    Madhav Gaikwad Tulsiram was appointed as a Director was appointed as a Director on 10 Jan 2017 & has been associated with this company since 9 years 2 months . was recorded as a recent event.

  • Director Appointment

    Nilesh Laxman Gajmal was appointed as a Director was appointed as a Director on 27 Dec 2016 & has been associated with this company since 9 years 2 months . was recorded as a recent event.

  • Charges

    A charge with State Bank Of Hyderabad amounted to Rs. 4.00 M with Charge ID 10549124 was registered on 20 Jan 2015. was recorded as a recent event.

  • Director Appointment

    Progress on Gautam Kumar Aniruddha Das was appointed as a Director was appointed as a Director on 14 Nov 2011 & has been associated with this company since 14 years 4 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Smega Pharmaceuticals Private Limited?

The CIN of Smega Pharmaceuticals Private Limited is U51909MH2011PTC223917.

Where is Smega Pharmaceuticals Private Limited headquartered?

Smega Pharmaceuticals Private Limited is headquartered at Office No.607, 6Th Floor, A-Wing Hermes Antrium Plot No.57, Sec-11,, Belapur, Maharashtra, 400614.

When was Smega Pharmaceuticals Private Limited incorporated?

Smega Pharmaceuticals Private Limited was incorporated on 14 November 2011.

Who are the current directors of Smega Pharmaceuticals Private Limited?

The current directors of Smega Pharmaceuticals Private Limited are

What is the primary industry of Smega Pharmaceuticals Private Limited?

The primary industry of Smega Pharmaceuticals Private Limited is Trade.

Is Smega Pharmaceuticals Private Limited a listed company?

Smega Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Smega Pharmaceuticals Private Limited?

The authorized capital of Smega Pharmaceuticals Private Limited is ₹0.20 M, and the paid-up capital is ₹0.14 M.

What is the compliance status of Smega Pharmaceuticals Private Limited?

The compliance status of Smega Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available